Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and observational findings without systematic search or meta-analysis
PubMed 22178787 · doi:10.1016/j.steroids.2011.12.003
What was done
Narrative review evaluating the mechanistic links between chronic low-grade inflammation, oxidative stress, mononuclear cell (MNC) activation, insulin resistance, and ovarian hyperandrogenism in women with polycystic ovary syndrome (PCOS).
What was found
The abstract reports conceptual and mechanistic findings without quantitative data or numerical statistics. It describes that glucose ingestion triggers oxidative stress and inflammatory responses from MNCs in PCOS independent of obesity. Glucose-stimulated tumor necrosis factor-alpha (TNFα) release and inflammatory markers correlate with insulin resistance and circulating androgens. While fasting hyperandrogenism sensitizes MNCs to glucose, chronic suppression of ovarian androgens does not resolve inflammation in normal-weight women with PCOS. In vitro evidence demonstrates that proinflammatory stimuli directly upregulate the ovarian theca cell steroidogenic enzymes responsible for androgen production.
Why it matters
This framework outlines how diet-triggered inflammation can act as an upstream driver of both metabolic and reproductive features in PCOS, rather than functioning merely as a secondary consequence of obesity.
Limits
As a narrative review, it lacks a systematic search methodology, risk-of-bias assessment, and pooled quantitative effect estimates. No sample sizes, patient counts, or numerical data are provided in the abstract. Key mechanistic conclusions rely partly on in vitro models and correlational observations.
Cited by
- supports Visceral fat releases inflammatory cytokines that worsen insulin resistance and stimulate ovarian androgen production.